Litigation Details for Theise v. Giles (D. Colo. 2018)
✉ Email this page to a colleague
Theise v. Giles (D. Colo. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-10-05 |
Court | District Court, D. Colorado | Date Terminated | 2020-08-31 |
Cause | 28:1332 Diversity-Breach of Fiduciary Duty | Assigned To | Richard Brooke Jackson |
Jury Demand | Plaintiff | Referred To | |
Parties | ERIC THEISE | ||
Patents | 8,513,196; 8,962,568; 8,969,308 | ||
Attorneys | Matthew Colin Cooper | ||
Firms | Goodwin Procter, LLP (Boston) | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Theise v. Giles
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Theise v. Giles (D. Colo. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-10-05 | 1 | • US 8,513,196 (Filtrate family) …coverage Worldwide Patent Coverage U.S. Patent Portfolio … Patent Term Extension … Pending Patent … FDA Protections Region Issued Patents (127) • FDA deemed Ampion | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |